This DB Chart Shows How the Tech Selloff Is Driving Moves Throughout the Stock Market
Serve Robotics Stock Continues To Soar: What's Going On?
These ETFs Let You Invest Based on Political Leanings - but Taking a Stance Can Be Costly
Bullish Sentiment Sees Biggest One-week Drop Since Feb 2023 in Latest AAII Survey
Nvidia, Alphabet, Microsoft, Drag S&P, Nasdaq Lower | Wall Street Today
6 days of consecutive sales! Berkshire Hathaway has a record amount of cash in hand, but remains steadfast in its shareholding of beloved Bank of America.
Some analysts believe that Buffett's shareholding reduction in Bank of America may be related to concerns about valuation. The current price of Bank of America has been getting closer to the level before the plunge of the US stock market in early 2022. In addition, tax rates may also be a possible reason. Regardless of the reason, based on Buffett's style, once the shareholding reduction starts, it will last for a considerable period of time.
Novo Nordisk Shares Decline Amid Competitive Pressure
Investors Go All In On Small Caps, Pour Over $6 Billion Into Russell 2000 ETF This Month: They 'Will Return To Larger-Cap Alternatives,' Veteran Analyst Says
Fed, FDIC, OCC Seek More Information From Banks on Bank-fintech Arrangements
Dow Leads Indexes Higher; GDP Beats Expectations
Express News | Manhattan DA Says Trump's Hush Money Conviction Should Stand; SCOTUS Ruling Has No Impact On Case
What's Going On With Tech Giant Meta's Stock Today?
Alphabet Stock Falls As OpenAI Plans 'SearchGPT': What Investors Need To Know
Ford Options Volume Jump as Stock Heads for Worst Slump Since 2008
Is the weight loss drug industry about to change? Viking Therapeutics rose nearly 40% intraday and hit a two-month high.
After communicating with the regulatory institution FDA, USA's Viking Therapeutics is pushing forward the weight-loss candidate drug VK2735 to phase III clinical trials ahead of schedule, potentially bringing the launch time forward by one year. This drug is expected to be injected once a month, which is more convenient than the same miraculous drug from Eli Lilly and Co and Novo Nordisk A/S. The oral version of VK2735 will start mid-term trials in the fourth quarter of this year.
Express News | Trump Leads Harris 48%-46% Among Registered Voters, NYT/Sienna College Poll Finds; Margin Of Error Is 3.3 Points
OpenAI Begins Testing AI-powered Search; GOOG Slips 2%
ServiceNow CEO Highlights Long-Running Partnership With Nvidia, 'Lightening Fast' AI Models That Run Inexpensively: 'We're The Unicorn'
Macquarie Downgrades Warner Bros. Discovery on Loss of NBA Rights to Amazon
Barclays Creates Growth-quality Basket for Targeted Approach to Small-cap Stocks